Saravana Gowtham Baskaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saravana Gowtham Baskaran has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alana M. Weaver
Department of Physics, Engineering and Astronomy, Earlham College, Richmond, Indiana
25 shared publications - Bernat Navarro-Serer
Friends of Cancer Research , Washington, DC 20036
25 shared publications - Brandi K. Glover
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland
25 shared publications - Daniel Wilentz
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland
25 shared publications - Daniele M. Gilkes
Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, USA
25 shared publications - Elana Judith Fertig
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA
25 shared publications
Latest Publications
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video S7 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of empty vector modified PDAC organoids in normoxia
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video S7 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of empty vector modified PDAC organoids in normoxia
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Figure 4 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Knockdown of P4HA1 decreases invasion in PDAC PDOs in hypoxia. A, Expression level of P4HA1 measured by qRT-PCR. Fold changes, expressed relative to the modified control samples, represent a mean of three technical replicates with SDs (PDO4 P = 0.0547, t test; PDO6 P = 0.0816, t test). B, Western blot analysis to confirm effectiveness of P4HA1 knockdown in PDO4 and PDO11 compared with the empty vector. C, Representative images of invasive shControl and shP4HA1_2-modified organoids in hypoxia. Scale bars, 100 μm. D, Effect of P4HA1 knockdown on invasion in modified PDO4 and PDO11 organoids. Percent invasion represents a mean of three biological replicates with SDs. Each biological replicate n > 30 organoids. (P = 0.0005 and P < 0.0001, t test). E, Inverse circularity scores of empty vector–modified and P4HA1 knockdown–modified PDO4 (top; n = 41 and n = 27, respectively; P = 0.0079, t test) and PDO11 (down; both n = 40; P < 0.0001, t test) organoids in hypoxia.
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 4 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Knockdown of P4HA1 decreases invasion in PDAC PDOs in hypoxia. A, Expression level of P4HA1 measured by qRT-PCR. Fold changes, expressed relative to the modified control samples, represent a mean of three technical replicates with SDs (PDO4 P = 0.0547, t test; PDO6 P = 0.0816, t test). B, Western blot analysis to confirm effectiveness of P4HA1 knockdown in PDO4 and PDO11 compared with the empty vector. C, Representative images of invasive shControl and shP4HA1_2-modified organoids in hypoxia. Scale bars, 100 μm. D, Effect of P4HA1 knockdown on invasion in modified PDO4 and PDO11 organoids. Percent invasion represents a mean of three biological replicates with SDs. Each biological replicate n > 30 organoids. (P = 0.0005 and P < 0.0001, t test). E, Inverse circularity scores of empty vector–modified and P4HA1 knockdown–modified PDO4 (top; n = 41 and n = 27, respectively; P = 0.0079, t test) and PDO11 (down; both n = 40; P < 0.0001, t test) organoids in hypoxia.
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video S8 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of P4HA1 overexpression modified PDAC organoids in normoxia
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video S8 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of P4HA1 overexpression modified PDAC organoids in normoxia
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Figure 1 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Hypoxia increases invasion in patient-derived PDAC organoids. A, Schematic of PDAC organoid culture generation, collection, study, and analysis timeline. B, Effect of hypoxia on invasion in PDO1, PDO4, and PDO11 organoids. Percent invasion represents a mean of minimum three biological replicates with SD. Each biological replicate n > 30 organoids (P = 0.015, P = 0.0032, and P = 0.1636, respectively, t test). C, Fold change of PDAC PDO sample invasion in normoxia and hypoxia. D, Representative images of PDO4 invasive organoids in normoxia and hypoxia. Scale bars, 100 μm. E, Inverse circularity scores of normoxic and hypoxic PDO1 (n = 15 and n = 29, respectively; P = 0.0122, t test), PDO4 (both n = 71; P = 0.0025, t test), and PDO11 (n = 44 and n = 54, respectively; P = 0.0024, t test) invasive organoids. F, Expression level of EMT markers (E-cadherin, N-cadherin, vimentin, and SNAIL) in PDO4 measured by qRT-PCR at multiple time points. Fold changes, expressed relative to normoxic control samples, represent a mean of three technical replicates with SD. G, Western blot analysis of EMT markers (fibronectin, E-cadherin, N-cadherin, and vimentin) in PDO4 in normoxia and hypoxia. H, hypoxia; N, normoxia.
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 1 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Hypoxia increases invasion in patient-derived PDAC organoids. A, Schematic of PDAC organoid culture generation, collection, study, and analysis timeline. B, Effect of hypoxia on invasion in PDO1, PDO4, and PDO11 organoids. Percent invasion represents a mean of minimum three biological replicates with SD. Each biological replicate n > 30 organoids (P = 0.015, P = 0.0032, and P = 0.1636, respectively, t test). C, Fold change of PDAC PDO sample invasion in normoxia and hypoxia. D, Representative images of PDO4 invasive organoids in normoxia and hypoxia. Scale bars, 100 μm. E, Inverse circularity scores of normoxic and hypoxic PDO1 (n = 15 and n = 29, respectively; P = 0.0122, t test), PDO4 (both n = 71; P = 0.0025, t test), and PDO11 (n = 44 and n = 54, respectively; P = 0.0024, t test) invasive organoids. F, Expression level of EMT markers (E-cadherin, N-cadherin, vimentin, and SNAIL) in PDO4 measured by qRT-PCR at multiple time points. Fold changes, expressed relative to normoxic control samples, represent a mean of three technical replicates with SD. G, Western blot analysis of EMT markers (fibronectin, E-cadherin, N-cadherin, and vimentin) in PDO4 in normoxia and hypoxia. H, hypoxia; N, normoxia.
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Figure 3 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
P4HA1 expression is increased in PDAC and is clinically relevant. A, Gene set enrichment analysis showing a correlation between a high P4HA1 expression and the expression of genes in a hypoxia gene signature (P = 3 × 10−20). B, scRNA-seq analysis shows increased expression levels of P4HA1 in human pancreatic tumors compared with normal tissue (P = 9 × 10−16). C, Protein expression of P4HA1 in PDAC using the Clinical Proteomic Tumor Analysis Consortium database, accessed through the University of Alabama at Birmingham Cancer data analysis Portal. D, Kaplan–Meier analysis of patients with PDAC shows increased risk of death associated with a high expression of P4HA1. Plot generated using KMPlot. The median survival time for low expression and high expression cohorts is 72.73 and 18.17 months, respectively (HR = 2.4; 95% confidence interval, 1.42–4.05; P = 0.00077).
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 3 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
P4HA1 expression is increased in PDAC and is clinically relevant. A, Gene set enrichment analysis showing a correlation between a high P4HA1 expression and the expression of genes in a hypoxia gene signature (P = 3 × 10−20). B, scRNA-seq analysis shows increased expression levels of P4HA1 in human pancreatic tumors compared with normal tissue (P = 9 × 10−16). C, Protein expression of P4HA1 in PDAC using the Clinical Proteomic Tumor Analysis Consortium database, accessed through the University of Alabama at Birmingham Cancer data analysis Portal. D, Kaplan–Meier analysis of patients with PDAC shows increased risk of death associated with a high expression of P4HA1. Plot generated using KMPlot. The median survival time for low expression and high expression cohorts is 72.73 and 18.17 months, respectively (HR = 2.4; 95% confidence interval, 1.42–4.05; P = 0.00077).
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Impact of P4HA1 knockdown on organoid invasion in normoxia
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Impact of P4HA1 knockdown on organoid invasion in normoxia
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Differentially expressed genes between normoxic and hypoxic invasive PDAC organoids
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Differentially expressed genes between normoxic and hypoxic invasive PDAC organoids
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video S6 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of P4HA1 knockdown modified PDAC organoids in normoxia
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video S6 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of P4HA1 knockdown modified PDAC organoids in normoxia
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Figure 2 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Comparison of transcriptomes and molecular pathways of invasive normoxic and hypoxic organoids. A, Principal component analysis plot of gene expression in hypoxic invasive organoid samples (n = 8). PC, principal component. B, Volcano plot of differentially expressed genes between normoxic and hypoxic invasive organoids. FC, fold change. C, Pathway analysis of normoxic and hypoxic invasive organoids using KEGG processes. D, Pathway analysis of normoxic and hypoxic invasive organoids using GO Biological Processes (GO-BP). E, IHC for hydroxyproline surrounding invasive and noninvasive organoids in PDO4 and PDO11. F, Western blot analysis assessing P4HA1 levels in 2D cultures prepared from PDO4 and PDO11 organoids 24 hours after treatment with a HIF1a inhibitor (10 μmol/L PX-478). H, hypoxia; N, normoxia.
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Comparison of transcriptomes and molecular pathways of invasive normoxic and hypoxic organoids. A, Principal component analysis plot of gene expression in hypoxic invasive organoid samples (n = 8). PC, principal component. B, Volcano plot of differentially expressed genes between normoxic and hypoxic invasive organoids. FC, fold change. C, Pathway analysis of normoxic and hypoxic invasive organoids using KEGG processes. D, Pathway analysis of normoxic and hypoxic invasive organoids using GO Biological Processes (GO-BP). E, IHC for hydroxyproline surrounding invasive and noninvasive organoids in PDO4 and PDO11. F, Western blot analysis assessing P4HA1 levels in 2D cultures prepared from PDO4 and PDO11 organoids 24 hours after treatment with a HIF1a inhibitor (10 μmol/L PX-478). H, hypoxia; N, normoxia.
- Open Access
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video S5 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of empty vector modified PDAC organoids in normoxia
- 30 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video S5 from P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids
Time-lapse analysis of empty vector modified PDAC organoids in normoxia